ANNE S CARLISLE FNP-C
Prescription History 1487650321
Nurse Practitioner in Eureka, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ANNE S CARLISLE FNP-C, an active Nurse Practitioner specialist practicing in Eureka, CA. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 74 documented patient claims. Among these therapy options, the most frequently utilized medication is Dutasteride, which accounts for 24 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Dutasteride | 24 | $27.49▼ below CA avg | ▼ Less than typical |
About Dutasteride: This medication is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It works by reducing the size of the enlarged prostate. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). It may also reduce the need for surgery to treat BPH. Dutasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. This medication should not be used by women or children. A 5-ALPHA-REDUCTASE INHIBITOR that is reported to inhibit both type-1 and type2 isoforms of the enzyme and is used to treat BENIGN PROSTATIC HYPERPLASIA. In 2024, this provider wrote 24 Medicare prescriptions for Dutasteride, about 60% of the volume of the typical California prescriber of this medication (39.8). Medicare paid an average of $27.49 per fill, versus $31.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 70 30-Day Fills standardized to 30-day supplies 2,100 Days of Medication total across all patients in 2024 | |||
| Dupixent PenDupilumab | 23 | $3,731.62▼ below CA avg | ≈ Typical |
About Dupixent Pen: This medication is used to treat certain skin conditions (eczema, prurigo nodularis) and a certain esophagus problem (eosinophilic esophagitis). Show more ▾ It is also used along with other medications to help control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD). In addition, dupilumab may be used to reduce symptoms caused by nasal polyps and the long-term swelling of the sinuses and nasal passage (chronic rhinosinusitis with nasal polyposis). Dupilumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking certain natural proteins in your body (interleukin-4 and interleukin-13) that may cause inflammation and swelling. This medication should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Targets the alpha subunit of interleukin-4 receptor. In 2024, this provider wrote 23 Medicare prescriptions for Dupixent Pen, about 77% of the volume of the typical California prescriber of this medication (29.9). Medicare paid an average of $3,731.62 per fill, versus $3,866.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 23 30-Day Fills standardized to 30-day supplies 644 Days of Medication total across all patients in 2024 | |||
| Terbinafine Hcl | 14 | $6.13▼ below CA avg | ▼ Less than typical |
About Terbinafine Hcl: Terbinafine is used to treat certain types of fungal infections (for example, of the fingernail or toenail). Show more ▾ It works by stopping the growth of fungus. This medication belongs to a class of drugs known as antifungals. A naphthalene derivative that inhibits fungal SQUALENE EPOXIDASE and is used to treat DERMATOMYCOSES of the skin and nails. In 2024, this provider wrote 14 Medicare prescriptions for Terbinafine Hcl, about half the volume of the typical California prescriber of this medication (24.9). Medicare paid an average of $6.13 per fill, versus $11.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 32.8 30-Day Fills standardized to 30-day supplies 975 Days of Medication total across all patients in 2024 | |||
| TremfyaGuselkumab | 13 | $13,031.83 | ≈ Typical |
About Tremfya: This medication is used to treat plaque psoriasis and psoriatic arthritis. Show more ▾ It is also used to treat a certain bowel disease (ulcerative colitis). Guselkumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural substance in your body (interleukin-23) that may cause inflammation and swelling. Specific for IL-23. In 2024, this provider wrote 13 Medicare prescriptions for Tremfya, about 75% of the volume of the typical California prescriber of this medication (17.3). Medicare paid an average of $13,031.83 per fill, versus $12,801.94 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.3 30-Day Fills standardized to 30-day supplies 728 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for ANNE S CARLISLE FNP-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Eureka, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
